Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger

  • 📰 CNBC
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, a source told CNBC.

Prenetics is a diagnostic and genetic testing company with significant operations in Hong Kong and the U.K.

Signage for Prenetics, a Hong Kong-based biotechnology company, at the company's laboratory in Hong Kong, China, on Jan. 26, 2018.Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the deal.

The transaction is expected to close by the end of this year. UBS, Citi, Credit Suisse and CICC are financial advisors on the potential de-SPAC transaction.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 12. in EG
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

What a forgettable name!

مصر أحدث الأخبار, مصر عناوين